Orchard therapeutics plc - adr
WebOrchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. WebBOSTON and LONDON, March 30, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company will make a virtual presentation at the...
Orchard therapeutics plc - adr
Did you know?
WebJul 2, 2024 · Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening … WebMar 24, 2024 · ORTX Stock Price Orchard Therapeutics PLC ADR Stock Quote (U.S.: Nasdaq) MarketWatch. Dow. 32,207.75. 102.50. 0.32%. S&P 500. 3,964.52. 15.80.
WebIndependent Director, Orchard Therapeutics Plc Steven M. Altschuler is an American businessperson who founded Spark Therapeutics, Inc. and who has been the head of 9 different companies. WebMar 2, 2024 · News for Orchard Therapeutics PLC ADR. Wednesday, March 15, 2024. 06:56 AM ET. Orchard Therapeutics stock price target raised to $22 from $4 at Stifel Nicolaus MarketWatch. Tuesday, November 16, 2024. 06:55 AM ET. Orchard Therapeutics downgraded to underweight from neutral at J.P. Morgan MarketWatch. Tuesday, March …
WebORCHARD THERAPEUTICS PLC (Name of Registrant as Specified In Its Charter) ... N.A. —ADR Shareholder Services by telephone: +1-877-248-4237 (toll free within the United States) or +1-781-575-4555 (for international callers) or by email: [email protected] or at Citibank, ... WebMar 6, 2024 · Orchard Therapeutics Plc ADR (ORTX) reported a Quarter December 2024 loss of $0.06 per share on revenue of $7.0 million. The consensus estimate was a loss of $0.18 per share on revenue of $5.0 million. Revenue grew …
WebNov 30, 2024 · Orchard Therapeutics plc - ADR (ORTX) shares closed today at 0.7% above its 52 week low of $1.35, giving the company a market cap of $176M. The stock is currently down 67.4% year-to-date, down 71. ...
WebNov 2, 2024 · InvestorsObserver is giving Orchard Therapeutics PLC - ADR (ORTX) an Analyst Rating Rank of 64, meaning ORTX is ranked higher by analysts than 64% of stocks. The average price target for ORTX is $13 and analyst’s rate the stock as a Strong Buy. Wall Street analysts are rating ORTX a Strong Buy today. pombe musichttp://www.adr.org/OfficeLocations shannon newth krtvWebBeurscodes, betekenis en hulp bij zoeken Europa AEX Euronext Amsterdam BRU Euronext Brussels PSE Euronext Paris LIS Euronext Lissabon CHX CBOE Europe, grote(re) EU aandelen shannon newellWebORTX - Orchard Therapeutics PLC ADR Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. shannon newth weddingWeb如果您是机构，请点击下方了解我们为ria、对冲基金、合规官员等提供的服务。 shannon newsWebFeb 23, 2024 · As of February 23, 2024, Orchard Therapeutics PLC - ADR had a $69.5 million market capitalization, putting it in the 28th percentile of companies in the Pharmaceuticals industry. Orchard Therapeutics PLC - ADR does not have a meaningful P/E due to negative earnings over the last 12 trailing months. shannon newth and jason lairdWeb东方财富网研报中心提供沪深两市最全面的上市公司公告信息，第一时间提供各上市公司最新公告，深入解析上市公司最新变化、重大事项。最大程度减少个人投资者与机构之间信息上的差异，使个人投资者更早的了解到上市公司基本面变化。 pom betting shop